Viewing Study NCT05806567


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2025-12-25 @ 11:08 PM
Study NCT ID: NCT05806567
Status: COMPLETED
Last Update Posted: 2025-09-25
First Post: 2023-03-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Assess the Effect of Oral Belumosudil on Inhibition of Various Proteins in the Fed State in Healthy Male Subjects
Sponsor: Kadmon, a Sanofi Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module